Walleye Capital
TBIO

Walleye Capital’s Telesis Bio, Inc. Common Stock TBIO Stock Holding History

Walleye Capital’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-615
Closed -$123 – 2376
2021
Q3 		$123 Buy
+615
New +$156K ﹤0.01% 1288

Other funds holding TBIO

NV
Northpond Ventures Bethesda, Maryland $43.7M AUM 27.27% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
OAM
Ophir Asset Management Sydney, Australia $859M AUM 59.08% 1-Year Est. Return
TCM
TimesSquare Capital Management New York $5.89B AUM 28.74% 1-Year Est. Return
PVI
Pura Vida Investments New York $14.9M AUM 38.76% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

Walleye Capital's TBIO Position: Q4 2021 in Review

Walleye Capital sold out of Telesis Bio, Inc. Common Stock (TBIO) in Q4 2021, closing a stake of 615 shares — an estimated $123 sold.

Walleye Capital first reported a position in TBIO in Q3 2021 and held it in 1 quarter. The position peaked at $123 in Q3 2021. 43 funds tracked by Wall St. Rank hold TBIO as of Q4 2021.

  • Walleye Capital reported no remaining Telesis Bio, Inc. Common Stock position as of Q4 2021 after selling out during the quarter.
  • Walleye Capital sold 615 Telesis Bio, Inc. Common Stock shares in Q4 2021, an estimated $123.
  • Walleye Capital first reported a position in Telesis Bio, Inc. Common Stock in Q3 2021 and held it in 1 quarter.
  • Walleye Capital's Telesis Bio, Inc. Common Stock position peaked at $123 in Q3 2021.
  • 43 funds tracked by Wall St. Rank held Telesis Bio, Inc. Common Stock as of Q4 2021.

Based on Walleye Capital's 13F filing for Q4 2021, filed 3 Mar 2022.